Bausch Health Companies (BHC) Revenue & Revenue Breakdown
Bausch Health Companies Revenue Highlights
Latest Revenue (Y)
$8.76B
Latest Revenue (Q)
$2.51B
Main Segment (Y)
Pharmaceutical Products
Main Geography (Y)
United States and Puerto Rico
Bausch Health Companies Revenue by Period
Bausch Health Companies Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $8.76B | 7.79% |
| 2022-12-31 | $8.12B | -3.68% |
| 2021-12-31 | $8.43B | 5.07% |
| 2020-12-31 | $8.03B | -6.67% |
| 2019-12-31 | $8.60B | 2.64% |
| 2018-12-31 | $8.38B | -3.94% |
| 2017-12-31 | $8.72B | -9.82% |
| 2016-12-31 | $9.67B | -7.86% |
| 2015-12-31 | $10.50B | 27.05% |
| 2014-12-31 | $8.26B | 43.22% |
| 2013-12-31 | $5.77B | 62.68% |
| 2012-12-31 | $3.55B | 43.97% |
| 2011-12-31 | $2.46B | 108.55% |
| 2010-12-31 | $1.18B | 43.98% |
| 2009-12-31 | $820.43M | 8.35% |
| 2008-12-31 | $757.18M | -10.16% |
| 2007-12-31 | $842.82M | -21.27% |
| 2006-12-31 | $1.07B | 14.42% |
| 2005-12-31 | $935.54M | 5.53% |
| 2004-12-31 | $886.54M | 7.63% |
| 2003-12-31 | $823.72M | 4.53% |
| 2002-12-31 | $788.02M | 35.11% |
| 2001-12-31 | $583.26M | 88.65% |
| 2000-12-31 | $309.17M | 75.17% |
| 1999-12-31 | $176.50M | 56.47% |
| 1998-12-31 | $112.80M | 36.89% |
| 1997-12-31 | $82.40M | 24.10% |
| 1996-12-31 | $66.40M | 222.33% |
| 1995-12-31 | $20.60M | 19.08% |
| 1994-12-31 | $17.30M | 55.86% |
| 1993-12-31 | $11.10M | - |
Bausch Health Companies generated $8.76B in revenue during NA 2023, up 7.79% compared to the previous quarter, and up 104.50% compared to the same period a year ago.
Bausch Health Companies Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $2.51B | 4.47% |
| 2024-06-30 | $2.40B | 12.09% |
| 2024-03-31 | $2.14B | -10.99% |
| 2023-12-31 | $2.41B | 7.60% |
| 2023-09-30 | $2.24B | 3.28% |
| 2023-06-30 | $2.17B | 11.47% |
| 2023-03-31 | $1.94B | -11.35% |
| 2022-12-31 | $2.19B | 7.18% |
| 2022-09-30 | $2.05B | 4.02% |
| 2022-06-30 | $1.97B | 2.55% |
| 2022-03-31 | $1.92B | -12.66% |
| 2021-12-31 | $2.20B | 4.03% |
| 2021-09-30 | $2.11B | 0.52% |
| 2021-06-30 | $2.10B | 3.60% |
| 2021-03-31 | $2.03B | -8.40% |
| 2020-12-31 | $2.21B | 3.51% |
| 2020-09-30 | $2.14B | 28.49% |
| 2020-06-30 | $1.66B | -17.30% |
| 2020-03-31 | $2.01B | -9.53% |
| 2019-12-31 | $2.22B | 0.68% |
| 2019-09-30 | $2.21B | 2.65% |
| 2019-06-30 | $2.15B | 6.75% |
| 2019-03-31 | $2.02B | -4.95% |
| 2018-12-31 | $2.12B | -0.70% |
| 2018-09-30 | $2.14B | 0.38% |
| 2018-06-30 | $2.13B | 6.67% |
| 2018-03-31 | $2.00B | -7.77% |
| 2017-12-31 | $2.16B | -2.52% |
| 2017-09-30 | $2.22B | -0.63% |
| 2017-06-30 | $2.23B | 5.88% |
| 2017-03-31 | $2.11B | -12.23% |
| 2016-12-31 | $2.40B | -3.09% |
| 2016-09-30 | $2.48B | 2.45% |
| 2016-06-30 | $2.42B | 2.05% |
| 2016-03-31 | $2.37B | -13.33% |
| 2015-12-31 | $2.74B | -1.81% |
| 2015-09-30 | $2.79B | 1.99% |
| 2015-06-30 | $2.73B | 24.72% |
| 2015-03-31 | $2.19B | -3.91% |
| 2014-12-31 | $2.28B | 10.88% |
| 2014-09-30 | $2.06B | 0.74% |
| 2014-06-30 | $2.04B | 8.21% |
| 2014-03-31 | $1.89B | -8.60% |
| 2013-12-31 | $2.06B | 33.86% |
| 2013-09-30 | $1.54B | 40.70% |
| 2013-06-30 | $1.10B | 2.57% |
| 2013-03-31 | $1.07B | 8.32% |
| 2012-12-31 | $986.29M | 11.55% |
| 2012-09-30 | $884.14M | 7.81% |
| 2012-06-30 | $820.09M | -4.21% |
| 2012-03-31 | $856.10M | 24.35% |
| 2011-12-31 | $688.45M | 14.63% |
| 2011-09-30 | $600.58M | -1.44% |
| 2011-06-30 | $609.39M | 7.85% |
| 2011-03-31 | $565.03M | 9.81% |
| 2010-12-31 | $514.56M | 147.07% |
| 2010-09-30 | $208.27M | -12.78% |
| 2010-06-30 | $238.77M | 8.71% |
| 2010-03-31 | $219.63M | -8.89% |
| 2009-12-31 | $241.05M | 13.42% |
| 2009-09-30 | $212.52M | 9.81% |
| 2009-06-30 | $193.53M | 11.66% |
| 2009-03-31 | $173.32M | -4.51% |
| 2008-12-31 | $181.50M | 0.22% |
| 2008-09-30 | $181.09M | -2.69% |
| 2008-06-30 | $186.09M | -10.74% |
| 2008-03-31 | $208.50M | 2.26% |
| 2007-12-31 | $203.90M | - |
Bausch Health Companies generated $2.51B in revenue during Q3 2024, up 4.47% compared to the previous quarter, and up 115.83% compared to the same period a year ago.
Bausch Health Companies Revenue Breakdown
Bausch Health Companies Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Pharmaceutical Products | $3.91B | - | - | - | - |
| Branded and Other Generic Products | $960.00M | - | - | - | - |
| Device Products | $2.00B | - | - | - | - |
| Other Revenues | $94.00M | - | - | - | - |
| Over the Counter Products | $1.80B | - | - | - | - |
| Product | - | $8.05B | $8.34B | $7.92B | $8.49B |
| Product and Service, Other | - | $78.00M | $92.00M | $103.00M | $112.00M |
Bausch Health Companies's latest annual revenue breakdown by segment (product or service), as of Dec 23: Pharmaceutical Products (44.64%), Device Products (22.80%), Over the Counter Products (20.52%), Branded and Other Generic Products (10.96%), and Other Revenues (1.07%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Products | $1.20B | $1.08B | $935.00M | $2.91B | $999.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Over the Counter Products | $472.00M | $490.00M | $437.00M | $1.34B | $457.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Revenues | $28.00M | $23.00M | $24.00M | $69.00M | $25.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Device Products | $567.00M | $547.00M | $512.00M | $1.50B | $494.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Branded and Other Generic Products | $245.00M | $258.00M | $245.00M | $697.00M | $263.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Product and Service, Other | - | - | - | - | - | $21.00M | $22.00M | $18.00M | $20.00M | $20.00M | $20.00M | $21.00M | $23.00M | $24.00M | $24.00M | $23.00M | $27.00M | $27.00M | $26.00M | $26.00M |
| Product | - | - | - | - | - | $2.15B | $1.92B | $2.17B | $2.03B | $1.95B | $1.90B | $2.17B | $2.09B | $2.08B | $2.00B | $2.19B | $2.11B | $1.64B | $1.99B | $2.20B |
Bausch Health Companies's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Pharmaceutical Products (47.73%), Device Products (22.59%), Over the Counter Products (18.80%), Branded and Other Generic Products (9.76%), and Other Revenues (1.12%).
Bausch Health Companies Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| CANADA | $366.00M | $351.00M | $343.00M | $331.00M | $339.00M |
| United States and Puerto Rico | $5.19B | $4.84B | $4.89B | $4.79B | $5.16B |
| SPAIN | $92.00M | $84.00M | $88.00M | $78.00M | $86.00M |
| POLAND | $319.00M | $278.00M | $280.00M | $238.00M | $231.00M |
| Other Countries | $1.01B | $887.00M | $986.00M | $1.01B | $995.00M |
| MEXICO | $322.00M | $276.00M | $256.00M | $225.00M | $228.00M |
| KOREA, REPUBLIC OF | $93.00M | $77.00M | - | - | - |
| JAPAN | $194.00M | $200.00M | $230.00M | $226.00M | $241.00M |
| ITALY | $86.00M | $76.00M | $80.00M | $85.00M | - |
| GERMANY | $152.00M | $147.00M | $154.00M | $144.00M | $150.00M |
| FRANCE | $214.00M | $203.00M | $208.00M | $179.00M | $201.00M |
| CHINA | $441.00M | $413.00M | $490.00M | $341.00M | $368.00M |
| EGYPT | - | - | $156.00M | $243.00M | $218.00M |
Bausch Health Companies's latest annual revenue breakdown by geography, as of Dec 23: United States and Puerto Rico (61.22%), Other Countries (11.92%), CHINA (5.20%), CANADA (4.31%), MEXICO (3.80%), POLAND (3.76%), FRANCE (2.52%), JAPAN (2.29%), GERMANY (1.79%), KOREA, REPUBLIC OF (1.10%), SPAIN (1.08%), and ITALY (1.01%).
Quarterly Revenue by Country
| Country | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KOREA, REPUBLIC OF | $38.00M | $34.00M | $30.00M | $24.00M | $24.00M | $23.00M | $22.00M | $19.00M | $19.00M | $20.00M | $19.00M | $20.00M | $20.00M | $16.00M | - | - | - | - | - | - |
| Other Countries | $263.00M | $272.00M | $256.00M | $279.00M | $242.00M | $252.00M | $238.00M | $240.00M | $221.00M | $207.00M | $219.00M | $220.00M | $264.00M | $241.00M | $250.00M | $289.00M | $267.00M | $204.00M | $239.00M | $257.00M |
| POLAND | $92.00M | $78.00M | $86.00M | $87.00M | $82.00M | $75.00M | $75.00M | $74.00M | $65.00M | $63.00M | $76.00M | $77.00M | $70.00M | $71.00M | $62.00M | $70.00M | $57.00M | $37.00M | $73.00M | $75.00M |
| SPAIN | $21.00M | $27.00M | $23.00M | $25.00M | $20.00M | $25.00M | $22.00M | $23.00M | $17.00M | $23.00M | $21.00M | $26.00M | $20.00M | $23.00M | $25.00M | $21.00M | $20.00M | $24.00M | - | - |
| United States and Puerto Rico | $1.53B | $1.44B | $1.25B | $1.46B | $1.36B | $1.27B | $1.11B | $1.31B | $1.22B | $1.19B | $1.11B | $1.26B | $1.25B | $1.22B | $1.16B | $1.27B | $1.30B | $1.01B | $1.21B | $1.31B |
| CANADA | $104.00M | $99.00M | $90.00M | $98.00M | $92.00M | $92.00M | $84.00M | $93.00M | $92.00M | $88.00M | $78.00M | $96.00M | $84.00M | $87.00M | $76.00M | $87.00M | $87.00M | $67.00M | $90.00M | $87.00M |
| CHINA | $132.00M | $122.00M | $97.00M | $126.00M | $113.00M | $114.00M | $88.00M | $120.00M | $116.00M | $74.00M | $103.00M | $141.00M | $120.00M | $119.00M | $110.00M | $110.00M | $94.00M | $79.00M | $58.00M | $92.00M |
| FRANCE | $52.00M | $65.00M | $61.00M | $45.00M | $49.00M | $63.00M | $57.00M | $44.00M | $44.00M | $58.00M | $57.00M | $48.00M | $50.00M | $56.00M | $54.00M | $48.00M | $42.00M | $42.00M | $47.00M | $45.00M |
| GERMANY | $40.00M | $41.00M | $44.00M | $33.00M | $34.00M | $42.00M | $43.00M | $35.00M | $55.00M | $35.00M | $45.00M | $38.00M | $36.00M | $28.00M | $42.00M | $36.00M | $32.00M | $32.00M | $44.00M | $31.00M |
| ITALY | $23.00M | $24.00M | $24.00M | $22.00M | $20.00M | $23.00M | $21.00M | $16.00M | $17.00M | $23.00M | $20.00M | $20.00M | $23.00M | - | - | - | - | - | - | - |
| JAPAN | $46.00M | $47.00M | $43.00M | $49.00M | $47.00M | $48.00M | $50.00M | $52.00M | $47.00M | $50.00M | $51.00M | $58.00M | $57.00M | $55.00M | $60.00M | $67.00M | $57.00M | $48.00M | $54.00M | $60.00M |
| MEXICO | $88.00M | $84.00M | $76.00M | $88.00M | $90.00M | $75.00M | $69.00M | $76.00M | $70.00M | $69.00M | $61.00M | $65.00M | $66.00M | $56.00M | $69.00M | $68.00M | $68.00M | $48.00M | $41.00M | $70.00M |
| EGYPT | - | - | - | - | - | - | - | - | - | - | - | $2.00M | $20.00M | $68.00M | $66.00M | $68.00M | $59.00M | $58.00M | $58.00M | $61.00M |
Bausch Health Companies's latest quarterly revenue breakdown by geography, as of Sep 24: United States and Puerto Rico (63.06%), Other Countries (10.81%), CHINA (5.42%), CANADA (4.27%), POLAND (3.78%), MEXICO (3.62%), FRANCE (2.14%), JAPAN (1.89%), GERMANY (1.64%), KOREA, REPUBLIC OF (1.56%), ITALY (0.94%), and SPAIN (0.86%).
Bausch Health Companies Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| TAK | Takeda Pharmaceutical Company | $4.26T | $1.05T |
| TEVA | Teva Pharmaceutical Industries | $15.85B | $4.16B |
| VTRS | Viatris | $15.43B | $3.66B |
| HLN | Haleon | $11.30B | $2.92B |
| BHC | Bausch Health Companies | $8.76B | $2.51B |
| ZTS | Zoetis | $8.54B | $2.36B |
| CTLT | Catalent | $4.38B | $1.07B |
| NBIX | Neurocrine Biosciences | $1.89B | $622.10M |
| EBS | Emergent BioSolutions | $1.05B | $254.70M |
| TLRY | Tilray Brands | $788.94M | $200.04M |
| LFCR | Lifecore Biomedical | $128.26M | $24.70M |
| PETQ | PetIQ | $1.10M | $328.94M |
| LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
| SHPH | Shuttle Pharmaceuticals | - | - |
BHC Revenue FAQ
What is Bausch Health Companies’s yearly revenue?
Bausch Health Companies's yearly revenue for 2023 was $8.76B, representing an increase of 7.79% compared to 2022. The company's yearly revenue for 2022 was $8.12B, representing a decrease of -3.68% compared to 2021. BHC's yearly revenue for 2021 was $8.43B, representing an increase of 5.07% compared to 2020.
What is Bausch Health Companies’s quarterly revenue?
Bausch Health Companies's quarterly revenue for Q3 2024 was $2.51B, a 4.47% increase from the previous quarter (Q2 2024), and a 12.15% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $2.4B, a 12.09% increase from the previous quarter (Q1 2024), and a 10.87% increase year-over-year (Q2 2023). BHC's quarterly revenue for Q1 2024 was $2.14B, a -10.99% decrease from the previous quarter (Q4 2023), and a 10.26% increase year-over-year (Q1 2023).
What is Bausch Health Companies’s revenue growth rate?
Bausch Health Companies's revenue growth rate for the last 3 years (2021-2023) was 3.83%, and for the last 5 years (2019-2023) was 1.81%.
What are Bausch Health Companies’s revenue streams?
Bausch Health Companies's revenue streams in c 23 are Pharmaceutical Products, Branded and Other Generic Products, Device Products, Other Revenues, and Over the Counter Products. Pharmaceutical Products generated $3.91B in revenue, accounting 44.64% of the company's total revenue Branded and Other Generic Products generated $960M in revenue, accounting 10.96% of the company's total revenue Device Products generated $2B in revenue, accounting 22.80% of the company's total revenue Other Revenues generated $94M in revenue, accounting 1.07% of the company's total revenue Over the Counter Products generated $1.8B in revenue, accounting 20.52% of the company's total revenue
What is Bausch Health Companies’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Bausch Health Companies was Pharmaceutical Products. This segment made a revenue of $3.91B, representing 44.64% of the company's total revenue.